a year ago
RARE
AnalystsSalveen RichterSalveen Richter's Stock Forecasts
AnalystsSalveen Richter
Analyst Ranking
Bottom 12%
#4362 out of 4928 analysts
Average Return
-1.2%
Win Rate
37%37 out of 100
Risk vs Reward
Poor
Good
Salveen Richter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | +569.03% | $23.51 | $157.29 | 2020-09-18 - 2021-09-17 | Strong Buy |
Passage Bio IncPASG | +150.07% | $14.02 | $35.06 | 2020-03-24 - 2020-06-25 | Strong Buy |
Denali Therapeutics IncDNLI | +149.21% | $27.98 | $69.73 | 2020-01-27 - 2021-01-27 | Strong Buy |
Moderna IncMRNA | +99.41% | $80.00 | $159.53 | 2020-05-18 - 2021-05-18 | Strong Buy |
Acorda Therapeutics IncACORQ | +89.11% | $1,939.20 | $211.20 | 2018-12-11 - 2019-12-11 | Strong Sell |
Salveen Richter Analyst Color
Get additional color on Salveen Richter's coverage of popular stocks
2 years ago
SAGE
3 years ago
ALLO
Salveen Richter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 5 | Hold | $29.00 | +59.38% | Downgrades | 17 days ago |
Enliven Therapeutics IncELVN | 1 | Strong Buy | $37.00 | +79.26% | Initiates Coverage On | 18 days ago |
4d Molecular Therapeutics IncFDMT | 4 | Strong Buy | $44.00 | +920.88% | Maintains | 2 months ago |
Crispr Therapeutics AgCRSP | 4 | Hold | $47.00 | -9.04% | Maintains | 2 months ago |
Arcus Biosciences IncRCUS | 3 | Hold | $13.00 | +51.34% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 1 | Strong Buy | $104.00 | +81.91% | Maintains | 2 months ago |
Summit Therapeutics IncSMMT | 2 | Strong Buy | $41.00 | +81.26% | Maintains | 2 months ago |
Amicus Therapeutics IncFOLD | 2 | Hold | $9.00 | +51.26% | Maintains | 2 months ago |
Adaptive Biotechnologies CorpADPT | 5 | Strong Buy | $10.00 | -12.89% | Maintains | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 4 | Strong Buy | $804.00 | +46.78% | Maintains | 2 months ago |
Biogen IncBIIB | 4 | Strong Buy | $197.00 | +47.91% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 8 | Hold | $32.00 | +79.57% | Maintains | 4 months ago |
Relay Therapeutics IncRLAY | 3 | Strong Buy | $18.00 | +400.00% | Maintains | 4 months ago |
Gilead Sciences IncGILD | 4 | Hold | $96.00 | -13.91% | Maintains | 5 months ago |
Moderna IncMRNA | 9 | Hold | $51.00 | +68.43% | Downgrades | 5 months ago |
Denali Therapeutics IncDNLI | 4 | Strong Buy | $40.00 | +168.46% | Maintains | 5 months ago |
Intellia Therapeutics IncNTLA | 6 | Hold | $12.00 | +11.84% | Maintains | 6 months ago |
Uniqure NvQURE | 7 | Hold | $20.00 | +40.06% | Maintains | 7 months ago |
Incyte CorpINCY | 5 | Hold | $70.00 | +2.68% | Maintains | 8 months ago |
Alnylam Pharmaceuticals IncALNY | 5 | Strong Buy | $370.00 | +12.20% | Upgrades | a year ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $76.00 | +92.60% | Maintains | a year ago |
Ionis Pharmaceuticals IncIONS | 3 | Strong Sell | $37.00 | -15.12% | Maintains | a year ago |
Sage Therapeutics IncSAGE | 6 | Hold | $11.00 | +21.15% | Maintains | a year ago |
Agios Pharmaceuticals IncAGIO | 5 | Hold | $53.00 | N/A | Maintains | a year ago |
Amgen IncAMGN | 3 | Strong Buy | $350.00 | N/A | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $559.00 | N/A | Maintains | a year ago |
2seventy Bio IncTSVT | 4 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Centessa Pharmaceuticals PLCCNTA | 4 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Allogene Therapeutics IncALLO | 4 | Strong Buy | $31.00 | N/A | Maintains | 2 years ago |
Autodesk IncADSK | 1 | Strong Buy | $225.00 | N/A | Maintains | 2 years ago |
Prime Medicine IncPRME | 1 | Hold | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Lyell Immunopharma IncLYEL | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Precision Biosciences IncDTIL | 5 | Hold | $30.00 | N/A | Maintains | 3 years ago |
Kronos Bio IncKRON | 2 | Strong Buy | $14.00 | N/A | Maintains | 3 years ago |
Recursion Pharmaceuticals IncRXRX | 3 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Taysha Gene Therapies IncTSHA | 2 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 6 | Strong Sell | $12.00 | N/A | Downgrades | 3 years ago |
Sana Biotechnology IncSANA | 2 | Hold | $6.00 | N/A | Maintains | 3 years ago |
Bread Financial Holdings IncBFH | 1 | Hold | $43.00 | N/A | Maintains | 3 years ago |
Bluebird Bio IncBLUE | 6 | Strong Sell | $60.00 | N/A | Maintains | 3 years ago |
Atara Biotherapeutics IncATRA | 1 | Strong Sell | $100.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $39.00 | N/A | Downgrades | 4 years ago |
Omega Therapeutics IncOMGAQ | 1 | Hold | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Sell | $10.00 | N/A | Downgrades | 4 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Passage Bio IncPASG | 3 | Strong Buy | $30.00 | N/A | Upgrades | 4 years ago |
Mirati Therapeutics IncMRTX | 1 | Strong Buy | $151.00 | N/A | Initiates Coverage On | 5 years ago |
Paccar IncPCAR | 3 | Hold | $50.00 | N/A | Maintains | 5 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Hold | $45.00 | N/A | Initiates Coverage On | 5 years ago |
Cellectis SaCLLS | 1 | Strong Sell | $11.00 | N/A | Downgrades | 5 years ago |
Seagen IncSGEN | 1 | Strong Buy | $165.00 | N/A | Maintains | 5 years ago |
Acorda Therapeutics IncACORQ | 4 | Strong Sell | $1,200.00 | N/A | Downgrades | 7 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Spark Therapeutics IncONCE | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.